Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQL Block and Quadriceps Weakness
NCT05023343Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Oct 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Zealand University Hospital. Primary endpoint: Maximum unilateral knee extension strength at 1 hour. Started Oct 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05023343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05023343.